Rheolution Article | January 2021
Methods to 3D print alginate-based scaffolds
by Dr. Dimitria Bonizol Camasao
Senior Application Specialist, Rheolution Inc.
During the first month of 2022, we focused on alginate hydrogels used in tissue engineering and drug delivery applications. As it has been discussed in the first publication of this topic, alginate is commonly used as bioink in 3D bioprinting to produce 3D structures (scaffolds) containing cells or bioactive molecules depending on the application. A particular feature of alginate solutions is their ability to quickly crosslink (have their molecules bonded together) in the presence of ions (e.g., Ca2+) resulting in a cohesive hydrogel that can be prepared in different shapes. And their final mechanical properties can be tuned (at least to a certain extent) by varying the components used in their preparation.
In the second publication of January 2022, alginate hydrogels were crosslinked with CaCl2 solution at different concentrations and incremental timing. Understanding the behavior of a specific formulation during crosslinking such as initiation time and speed of gelation, and potential swelling and shrinking related to this gelation process is essential to better design experiments especially for 3D printing.
For extrusion 3D printing technique, numerous methods have been developed to print alginate 3D structures. Alginate solution has a relatively low viscosity and to be able to print it pure and post crosslink it, a laborious optimization of the protocol is required. For example, bioink’s manufacturers do have detailed protocols that were developed for printing their bioinks at a specific concentration within their suggested range of printing speed, extrusion pressure, nozzle size, temperature, among others. One example is the alginate used in one of our published application notes. Cellink developed a detailed protocol for the printing of their bioink in their extrusion 3D printers.
When a protocol for printing pure alginate solution is not readily available or challenging to obtain, different methods were also developed to overcome its low viscosity. Some reported methods include (Section A in Figure 1) the pre crosslinking of the alginate solution in the syringe barrel with CaCl2 solution for up to 30 min before printing [1,2], (Section B in Figure 1) the use of a coaxial needle with alginate and CaCl2 solution in the shell and core, respectively, for rapid crosslinking as soon as they come out from the needle during the printing process [3], and very common, (Section C in Figure 1) the mixing with other biomaterials such as gelatin, agar, PEG, among others to improve the immediate printability [4].
In addition, a relatively new printing method recommended for improving printing fidelity of soft biomaterials, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), can also be used to print pure alginate structures [5]. In this technique (Section D in Figure 1), the bioink is extruded in a supporting bath composed of a sacrificial hydrogel that holds the bioink in place until it gelifies. In the case of alginate, the support bath should also contain calcium chloride for triggering the crosslinking. Altogether, the FRESH printing provides an unmatched combination of capabilities in terms of bioinks, resolution, size and 3D geometric complexity that can be used and/or achieved.
In addition, a relatively new printing method recommended for improving printing fidelity of soft biomaterials, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), can also be used to print pure alginate structures [5]. In this technique (Section D in Figure 1), the bioink is extruded in a supporting bath composed of a sacrificial hydrogel that holds the bioink in place until it gelifies. In the case of alginate, the support bath should also contain calcium chloride for triggering the crosslinking. Altogether, the FRESH printing provides an unmatched combination of capabilities in terms of bioinks, resolution, size and 3D geometric complexity that can be used and/or achieved.
Being pure or mixed with other biomaterials, alginate provides to the scaffold an inherent biocompatibility, relatively low cost, low toxicity, mild and tunable gelation with the addition of divalent cations that are important factors for the encapsulation of cells or bioactive molecules.
ElastoSens™ Bio
ElastoSens™ Bio
References
[1] Freeman, F. E., & Kelly, D. J. (2017). Tuning alginate bioink stiffness and composition for controlled growth factor delivery and to spatially direct MSC fate within bioprinted tissues. Scientific reports, 7(1), 1-12.
[2] Daly, A. C., Critchley, S. E., Rencsok, E. M., & Kelly, D. J. (2016). A comparison of different bioinks for 3D bioprinting of fibrocartilage and hyaline cartilage. Biofabrication, 8(4), 045002.
[3] Zhang, Y., Yu, Y., Chen, H., & Ozbolat, I. T. (2013). Characterization of printable cellular micro-fluidic channels for tissue engineering. Biofabrication, 5(2), 025004.
[4] Mallakpour, S., Azadi, E., & Hussain, C. M. (2021). State-of-the-art of 3D printing technology of alginate-based hydrogels—An emerging technique for industrial applications. Advances in Colloid and Interface Science, 102436.
[5] Shiwarski, D. J., Hudson, A. R., Tashman, J. W., & Feinberg, A. W. (2021). Emergence of FRESH 3D printing as a platform for advanced tissue biofabrication. APL bioengineering, 5(1), 010904.
Related Posts
Ever fantasized about sci-fi healing tanks? The principle of neutral buoyancy behind them has sparked a unique solution for 3D printing with soft, liquid-like inks. The Freeform Reversible Embedding of Suspended Hydrogels (FRESH) bioprinting technique has been developed to support the printing of these tricky materials, ideal for tissue engineering applications. The secret lies in a cleverly engineered support bath, able to hold the soft structures while permitting extruder needle movement. With versatility, high cell viability, and potential for large construct printing, FRESH opens up a world of possibilities, bringing us a step closer to 3D bioprinting patient-specific tissues based on anatomical data.
Exploring the frontier of 3D printing, Cornell University researchers have enhanced the Freeform Reversible Embedding of Suspended Hydrogels (FRESH) method. They introduced a computational approach for non-planar printing, enabling complex curved structures, improving printing accuracy and augmenting the mechanical properties of bioprints.
4D bioprinting introduces "time" as the fourth dimension, enabling printed objects to change over time. Physical stimuli like light, temperature, or magnetism can induce transformations. The bioprinting process can also allow targeted drug release through changes in temperature or pH. Nano-hydrogels can serve as drug carriers, directed by magnetic fields, and can be quickly degraded by enzymes. Furthermore, hydrogels can react to biological signals, aiding in tumor treatment by releasing drugs then biodegrading over time.
4D-bioprinting introduces "time" into the printing process, allowing printed structures to evolve. Researchers from the University of Illinois Chicago used oxidized and methacrylated alginate (OMA) to develop a bioink for 4D bioprinting. They made OMA into precursor beads, then transformed them into a "microgel" that could be easily printed into stable 3D constructs. Mixed with cells, the microgel became a bioink, which was printed into complex structures. The printed constructs could be further crosslinked to create 3D scaffolds that could change shape due to differential swelling, adding the 4th dimension, "time," to the printing process.
3D-bioprinting involves printing a biomaterial or 'bioink' that contains cells, forming structures similar to living tissues. The process requires careful optimization to ensure the material holds its shape and function, and that the cells survive the printing process. Current bioprinting techniques, such as extrusion, inkjet and laser-assisted bioprinting, come with their own advantages and limitations. The ultimate goal is to bring in vitro bioprinting into the operating room, overcoming challenges like sterility, regulation, and ethical considerations.
Recent advancements in 3D-bioprinting have opened the possibility of creating engineered tissues mimicking human native tissues. However, reproducing the extracellular matrix (ECM) composition and microscopic architecture within the biomaterial ink remains challenging. To tackle this, a research group from the AO Research Institute Davos developed a bioink containing both collagen type 1 and tyramine derivative hyaluronan for tissue engineering. They used optimal concentrations of these two components, along with human bone marrow-derived mesenchymal stromal cells. Two crosslinking pathways were used to induce gelation and create a 3D scaffold that was then printed using the bioink's shear-thinning properties. They successfully printed an anisotropic hydrogel, achieving control over the microscopic organization of the matrix. This breakthrough could pave the way for better mimicry of native human tissues, especially anisotropic ones, in tissue engineering applications.